img

Global Canine Arthritis Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Canine Arthritis Treatment Market Insights, Forecast to 2034

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
Market Analysis and InsightsGlobal Canine Arthritis Treatment Market
Global Canine Arthritis Treatment market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Canine Arthritis Treatment industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Canine Arthritis Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Canine Arthritis Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids

Segment by Application


Veterinary Hospitals and Clinics
Drug Stores
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Canine Arthritis Treatment introduction, etc. Canine Arthritis Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Canine Arthritis Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Canine Arthritis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Drug Stores
1.3.4 E-commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Treatment Market Perspective (2018-2033)
2.2 Global Canine Arthritis Treatment Growth Trends by Region
2.2.1 Canine Arthritis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Canine Arthritis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Canine Arthritis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Canine Arthritis Treatment Market Dynamics
2.3.1 Canine Arthritis Treatment Industry Trends
2.3.2 Canine Arthritis Treatment Market Drivers
2.3.3 Canine Arthritis Treatment Market Challenges
2.3.4 Canine Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Canine Arthritis Treatment by Players
3.1.1 Global Canine Arthritis Treatment Revenue by Players (2018-2023)
3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Canine Arthritis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Canine Arthritis Treatment Market Concentration Ratio
3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2022
3.5 Global Key Players of Canine Arthritis Treatment Head office and Area Served
3.6 Global Key Players of Canine Arthritis Treatment, Product and Application
3.7 Global Key Players of Canine Arthritis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Treatment Breakdown Data by Type
4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033)
5 Canine Arthritis Treatment Breakdown Data by Application
5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Canine Arthritis Treatment Market Size (2018-2033)
6.2 North America Canine Arthritis Treatment Market Size by Type
6.2.1 North America Canine Arthritis Treatment Market Size by Type (2018-2023)
6.2.2 North America Canine Arthritis Treatment Market Size by Type (2024-2033)
6.2.3 North America Canine Arthritis Treatment Market Share by Type (2018-2033)
6.3 North America Canine Arthritis Treatment Market Size by Application
6.3.1 North America Canine Arthritis Treatment Market Size by Application (2018-2023)
6.3.2 North America Canine Arthritis Treatment Market Size by Application (2024-2033)
6.3.3 North America Canine Arthritis Treatment Market Share by Application (2018-2033)
6.4 North America Canine Arthritis Treatment Market Size by Country
6.4.1 North America Canine Arthritis Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Canine Arthritis Treatment Market Size by Country (2018-2023)
6.4.3 North America Canine Arthritis Treatment Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size (2018-2033)
7.2 Europe Canine Arthritis Treatment Market Size by Type
7.2.1 Europe Canine Arthritis Treatment Market Size by Type (2018-2023)
7.2.2 Europe Canine Arthritis Treatment Market Size by Type (2024-2033)
7.2.3 Europe Canine Arthritis Treatment Market Share by Type (2018-2033)
7.3 Europe Canine Arthritis Treatment Market Size by Application
7.3.1 Europe Canine Arthritis Treatment Market Size by Application (2018-2023)
7.3.2 Europe Canine Arthritis Treatment Market Size by Application (2024-2033)
7.3.3 Europe Canine Arthritis Treatment Market Share by Application (2018-2033)
7.4 Europe Canine Arthritis Treatment Market Size by Country
7.4.1 Europe Canine Arthritis Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Canine Arthritis Treatment Market Size by Country (2018-2023)
7.4.3 Europe Canine Arthritis Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Canine Arthritis Treatment Market Size (2018-2033)
8.2 China Canine Arthritis Treatment Market Size by Type
8.2.1 China Canine Arthritis Treatment Market Size by Type (2018-2023)
8.2.2 China Canine Arthritis Treatment Market Size by Type (2024-2033)
8.2.3 China Canine Arthritis Treatment Market Share by Type (2018-2033)
8.3 China Canine Arthritis Treatment Market Size by Application
8.3.1 China Canine Arthritis Treatment Market Size by Application (2018-2023)
8.3.2 China Canine Arthritis Treatment Market Size by Application (2024-2033)
8.3.3 China Canine Arthritis Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Canine Arthritis Treatment Market Size (2018-2033)
9.2 Asia Canine Arthritis Treatment Market Size by Type
9.2.1 Asia Canine Arthritis Treatment Market Size by Type (2018-2023)
9.2.2 Asia Canine Arthritis Treatment Market Size by Type (2024-2033)
9.2.3 Asia Canine Arthritis Treatment Market Share by Type (2018-2033)
9.3 Asia Canine Arthritis Treatment Market Size by Application
9.3.1 Asia Canine Arthritis Treatment Market Size by Application (2018-2023)
9.3.2 Asia Canine Arthritis Treatment Market Size by Application (2024-2033)
9.3.3 Asia Canine Arthritis Treatment Market Share by Application (2018-2033)
9.4 Asia Canine Arthritis Treatment Market Size by Region
9.4.1 Asia Canine Arthritis Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Canine Arthritis Treatment Market Size by Region (2018-2023)
9.4.3 Asia Canine Arthritis Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Elanco (Eli Lilly and Company)
11.1.1 Elanco (Eli Lilly and Company) Company Details
11.1.2 Elanco (Eli Lilly and Company) Business Overview
11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction
11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2018-2023)
11.1.5 Elanco (Eli Lilly and Company) Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Details
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction
11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.3.5 Zoetis Inc Recent Developments
11.4 Vetoquinol S.A.
11.4.1 Vetoquinol S.A. Company Details
11.4.2 Vetoquinol S.A. Business Overview
11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction
11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2018-2023)
11.4.5 Vetoquinol S.A. Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Canine Arthritis Treatment Introduction
11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2018-2023)
11.5.5 Bayer AG Recent Developments
11.6 Aratana Therapeutics Inc
11.6.1 Aratana Therapeutics Inc Company Details
11.6.2 Aratana Therapeutics Inc Business Overview
11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction
11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.6.5 Aratana Therapeutics Inc Recent Developments
11.7 Norbrook Laboratories Limited
11.7.1 Norbrook Laboratories Limited Company Details
11.7.2 Norbrook Laboratories Limited Business Overview
11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction
11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2018-2023)
11.7.5 Norbrook Laboratories Limited Recent Developments
11.8 VetStem Biopharma
11.8.1 VetStem Biopharma Company Details
11.8.2 VetStem Biopharma Business Overview
11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction
11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2018-2023)
11.8.5 VetStem Biopharma Recent Developments
11.9 Dechra Pharmaceuticals Plc
11.9.1 Dechra Pharmaceuticals Plc Company Details
11.9.2 Dechra Pharmaceuticals Plc Business Overview
11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction
11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.9.5 Dechra Pharmaceuticals Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Global Canine Arthritis Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Canine Arthritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Canine Arthritis Treatment Market Share by Region (2018-2023)
Table 8. Global Canine Arthritis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Canine Arthritis Treatment Market Share by Region (2024-2033)
Table 10. Canine Arthritis Treatment Market Trends
Table 11. Canine Arthritis Treatment Market Drivers
Table 12. Canine Arthritis Treatment Market Challenges
Table 13. Canine Arthritis Treatment Market Restraints
Table 14. Global Canine Arthritis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Canine Arthritis Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top Canine Arthritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
Table 17. Global Canine Arthritis Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Canine Arthritis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Canine Arthritis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Canine Arthritis Treatment, Product and Application
Table 21. Global Key Players of Canine Arthritis Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Canine Arthritis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Canine Arthritis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Canine Arthritis Treatment Revenue Share by Application (2018-2023)
Table 29. Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Canine Arthritis Treatment Revenue Share by Application (2024-2033)
Table 31. North America Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Canine Arthritis Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Canine Arthritis Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Canine Arthritis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Canine Arthritis Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Canine Arthritis Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Canine Arthritis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Canine Arthritis Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Canine Arthritis Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Canine Arthritis Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Canine Arthritis Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Canine Arthritis Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Canine Arthritis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Canine Arthritis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 63. Elanco (Eli Lilly and Company) Company Details
Table 64. Elanco (Eli Lilly and Company) Business Overview
Table 65. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product
Table 66. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 67. Elanco (Eli Lilly and Company) Recent Developments
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Canine Arthritis Treatment Product
Table 71. Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Developments
Table 73. Zoetis Inc Company Details
Table 74. Zoetis Inc Business Overview
Table 75. Zoetis Inc Canine Arthritis Treatment Product
Table 76. Zoetis Inc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 77. Zoetis Inc Recent Developments
Table 78. Vetoquinol S.A. Company Details
Table 79. Vetoquinol S.A. Business Overview
Table 80. Vetoquinol S.A. Canine Arthritis Treatment Product
Table 81. Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 82. Vetoquinol S.A. Recent Developments
Table 83. Bayer AG Company Details
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Canine Arthritis Treatment Product
Table 86. Bayer AG Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 87. Bayer AG Recent Developments
Table 88. Aratana Therapeutics Inc Company Details
Table 89. Aratana Therapeutics Inc Business Overview
Table 90. Aratana Therapeutics Inc Canine Arthritis Treatment Product
Table 91. Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 92. Aratana Therapeutics Inc Recent Developments
Table 93. Norbrook Laboratories Limited Company Details
Table 94. Norbrook Laboratories Limited Business Overview
Table 95. Norbrook Laboratories Limited Canine Arthritis Treatment Product
Table 96. Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 97. Norbrook Laboratories Limited Recent Developments
Table 98. VetStem Biopharma Company Details
Table 99. VetStem Biopharma Business Overview
Table 100. VetStem Biopharma Canine Arthritis Treatment Product
Table 101. VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 102. VetStem Biopharma Recent Developments
Table 103. Dechra Pharmaceuticals Plc Company Details
Table 104. Dechra Pharmaceuticals Plc Business Overview
Table 105. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product
Table 106. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 107. Dechra Pharmaceuticals Plc Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Canine Arthritis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Opioids Features
Figure 5. Global Canine Arthritis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Canine Arthritis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Veterinary Hospitals and Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. E-commerce Case Studies
Figure 10. Canine Arthritis Treatment Report Years Considered
Figure 11. Global Canine Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Canine Arthritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Canine Arthritis Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Canine Arthritis Treatment Market Share by Players in 2022
Figure 15. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Canine Arthritis Treatment Revenue in 2022
Figure 17. North America Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Canine Arthritis Treatment Market Share by Type (2018-2033)
Figure 19. North America Canine Arthritis Treatment Market Share by Application (2018-2033)
Figure 20. North America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 21. United States Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Canine Arthritis Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Canine Arthritis Treatment Market Share by Type (2018-2033)
Figure 25. Europe Canine Arthritis Treatment Market Share by Application (2018-2033)
Figure 26. Europe Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 27. Germany Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Canine Arthritis Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Canine Arthritis Treatment Market Share by Type (2018-2033)
Figure 35. China Canine Arthritis Treatment Market Share by Application (2018-2033)
Figure 36. Asia Canine Arthritis Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Canine Arthritis Treatment Market Share by Type (2018-2033)
Figure 38. Asia Canine Arthritis Treatment Market Share by Application (2018-2033)
Figure 39. Asia Canine Arthritis Treatment Market Share by Region (2018-2033)
Figure 40. Japan Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 50. Brazil Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 58. Zoetis Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 59. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 60. Bayer AG Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 61. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 62. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 63. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 64. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries